PF-1355 is an oral myeloperoxidase (MPO) inhibitor that successfully decreased elevated
MPO activity in mouse myocardial infarction models. Short duration PF-1355 treatment for 7 …

Sudden cardiac death (SCD) accounts for> 300 000 deaths in the United States annually. 1
Although the majority of these deaths occur in low-risk populations2 in which aggressive …

Objective We aimed to assess the pattern of mortality and cause of death in a cohort of
patients with ST-segment elevation myocardial infarction (STEMI) treated with primary …

Background: Prehospital ECG improves survival following ST-segment elevation myocardial
infarction (STEMI). Although a new International Consensus on Cardiopulmonary …

Sympathetic and parasympathetic control of the heart is a classic example of norepinephrine
(NE) and acetylcholine (ACh) triggering opposing actions. Sympathetic NE increases heart …

Aims Baicalein is a widely used Chinese herbal medicine extracted from Labiatae plants
Scutellaria baicalensis Georgi's dry root, which has multiple pharmacological activities …

Background Doberman Pinschers with dilated cardiomyopathy (DCM) are at high risk of
sudden cardiac death (SCD). Risk factors for SCD are poorly defined. Aim To assess cardiac …

The 'Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator
Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction'(PROTECT …

Importance In the current therapeutic era, the risk for sudden cardiac death (SCD) after non–
ST-segment elevation acute coronary syndrome (NSTE ACS) has not been characterized …

Primary percutaneous coronary intervention (pPCI) largely reduced the rate of left ventricular
(LV) dysfunction after ST-segment elevation acute myocardial infarction (STEMI). Though LV …